Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Net Margin (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Net Margin for 15 consecutive years, with 3.12% as the latest value for Q3 2025.

  • On a quarterly basis, Net Margin fell 842.0% to 3.12% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.92%, a 438.0% decrease, with the full-year FY2024 number at 4.92%, down 200.0% from a year prior.
  • Net Margin was 3.12% for Q3 2025 at Usana Health Sciences, down from 4.43% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 9.96% in Q4 2021 to a low of 238962.5% in Q3 2021.
  • A 5-year average of 15075.23% and a median of 5.61% in 2022 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: crashed -23897330bps in 2021, then surged 23896974bps in 2022.
  • Usana Health Sciences' Net Margin stood at 9.96% in 2021, then crashed by -44bps to 5.61% in 2022, then surged by 35bps to 7.58% in 2023, then tumbled by -72bps to 2.1% in 2024, then tumbled by -249bps to 3.12% in 2025.
  • Per Business Quant, the three most recent readings for USNA's Net Margin are 3.12% (Q3 2025), 4.43% (Q2 2025), and 3.72% (Q1 2025).